Skip to Main Content
Table 5

Average concentrations (Min-Max) measured during the observation period (14 months) for 15 relevant compounds (ng L−1) and VF removal efficiencies (%), N=12

CompoundIN VF (ng L−1)EF VF (ng L−1)Elimination VF (%)
Carbamazepine 529 (96–1,290) 6 (4–13) 98 
Clarithromycin 276 (61–583) 14 (3–43) 95 
Ciprofloxacin 218 (147–357) 36 (5–178) 92 
Diclofenac 1,523 (481–2,508) 11 (4–31) 99 
Lidocaine 122 (32–231) 4 (3–20) 97 
Metoprolol 363 (202–720) 24 (5–80) 93 
Propranolol 131 (31–265) 13 (5–42) 88 
N-acetyl sulfamethoxazole 10 (4–28) 4 (3–5) 45 
Sulfamethoxazole 79 (18–176) 5 (4–7) 89 
Benzotriazole 2,337 (1,049–3,493) 17 (8–39) 99 
TCPP 3,002 (1,076–5,218) 2,075 (707–5,761) 26 
Tolyltriazole 1,000 (505–1,337) 11 (4–41) 99 
Glyphosate 127 (60–193) 19 (5–49) 85 
AMPA 4,079 (1,500–9,460) 2,634 (66–5,720) 25 
PFOS 61 (5–246) 19 (5–67) 62 
CompoundIN VF (ng L−1)EF VF (ng L−1)Elimination VF (%)
Carbamazepine 529 (96–1,290) 6 (4–13) 98 
Clarithromycin 276 (61–583) 14 (3–43) 95 
Ciprofloxacin 218 (147–357) 36 (5–178) 92 
Diclofenac 1,523 (481–2,508) 11 (4–31) 99 
Lidocaine 122 (32–231) 4 (3–20) 97 
Metoprolol 363 (202–720) 24 (5–80) 93 
Propranolol 131 (31–265) 13 (5–42) 88 
N-acetyl sulfamethoxazole 10 (4–28) 4 (3–5) 45 
Sulfamethoxazole 79 (18–176) 5 (4–7) 89 
Benzotriazole 2,337 (1,049–3,493) 17 (8–39) 99 
TCPP 3,002 (1,076–5,218) 2,075 (707–5,761) 26 
Tolyltriazole 1,000 (505–1,337) 11 (4–41) 99 
Glyphosate 127 (60–193) 19 (5–49) 85 
AMPA 4,079 (1,500–9,460) 2,634 (66–5,720) 25 
PFOS 61 (5–246) 19 (5–67) 62 
Close Modal

or Create an Account

Close Modal
Close Modal